RIGHTS GRANTED 2 Sample Clauses

RIGHTS GRANTED 2. ПРЕДОСТАВЛЯЕМЫЕ ПРАВА 2.1 Your Hardware order consists of the following items: Operating System (as defined in Your configuration), Integrated Software and all Hardware equipment (including components, options and spare parts) specified on the applicable order. Your Hardware order may also include Integrated Software Options. Integrated Software Options may not be activated or used until You separately order them and agree to pay additional fees. 2.1 Ваш заказ на Оборудование включает в себя следующие позиции: Операционная система (как указано в Вашей конфигурации), Интегрированное программное обеспечение и все Оборудование (включая компоненты, необязательные компоненты и запасные части), указанные в соответствующем заказе. Ваш заказ на Оборудование может также включать Опции Интегрированного программного обеспечения. Опции Интегрированного программного обеспечения могут не активироваться и не использоваться до тех пор, пока Вы не оформите на них отдельный заказ и не дадите согласие на уплату дополнительной стоимости. 2.2 You have the right to use the Operating System delivered with the Hardware subject to the terms of the license agreement(s) delivered with the Hardware. Current versions of the license agreements are located at xxxx://xxxxxx.xxx/contracts. You are licensed to use the Operating System and any Operating System updates acquired through technical support only as incorporated in, and as part of, the Hardware.
Sample 1
AutoNDA by SimpleDocs
RIGHTS GRANTED 2. SUTEIKTOS TEISĖS 2.1 Your Hardware order consists of the following items: Operating System (as defined in Your configuration), Integrated Software and all Hardware equipment (including components, options and spare parts) specified on the applicable order. Your Hardware order may also include Integrated Software Options. Integrated Software Options may not be activated or used until You separately order them and agree to pay additional fees. 2.1. Jūsų Techninės įrangos užsakymą sudaro tokie elementai: Operacinė sistema (kaip nurodyta Jūsų konfigūracijoje), Integruotoji programinė įranga ir visa Techninė įranga (įskaitant komponentus, parinktis ir atsargines dalis), nurodyta atitinkamame užsakyme. Jūsų Techninės įrangos užsakymas taip pat gali apimti Integruotosios programinės įrangos parinktis. Integruotosios programinės įrangos parinktys negali būti suaktyvintos arba naudojamos tol, kol jų atskirai neužsisakysite ir nesutiksite sumokėti papildomų įmokų. 2.2 You have the right to use the Operating System delivered with the Hardware subject to the terms of the license agreement(s) delivered with the Hardware. Current versions of the license agreements are located at xxxx://xxxxxx.xxx/contracts. You are licensed to use the Operating System and any Operating System updates acquired through technical support only as incorporated in, 2.
Sample 1
RIGHTS GRANTED 2. 1 Subject to the Third Party Rights MRC hereby grants to CAT during the continuance of this Agreement the following rights and licences under the Patent Rights and the Technology on the following conditions: Exclusive Rights ---------------- 2.1.1 the exclusive right and licence under CAT License Conditions to identify, develop, make, have made, import, market and sell antibodies for human in vivo use which are not antibodies the subject of Clause 2.1.7 and for the avoidance of doubt it is declared and agreed that such exclusive right and licence includes using an antibody gene as a therapeutic entity in gene therapy provided always that CAT will subject to the conditions below grant up to [***] exclusive sub-licences to develop, make, have made, use, import, market and sell a specific antibody product directed at a particular antigen (for the avoidance of doubt it is declared antibodies derived from [***] would count within this total) to the Collaborative Centre (but excluding any right of access or licence to use CAT Libraries) with the right for the Collaborative Centre to sub-sub licence for royalties payable by the Collaborative Centre to CAT and on financial terms [***]. The Collaborative Centre may from time to time submit to CAT a written request asking CAT to state whether a sub-licence to a specific antigen is available. Within 30 days of such written request CAT shall respond in writing in either the affirmative or the negative. CAT shall respond in the affirmative to the Collaborative Centre provided that the antigen is not at the time of the Collaborative Centre request: [***] In the event of an affirmative response CAT shall grant no licence or other interest under its intellectual property which would prevent the grant of such a sub-licence for a period of [***] from the date of the Collaborative Centre's original request to CAT. An antigen reserved in this way shall be called a "Reserved Antigen." The Collaborative Centre shall be entitled to reserve a maximum of [***] Reserved Antigens in this way i.e. may replace up to [***] reservations with a new reservation. The Collaborative Centre shall inform CAT in writing when it wishes to obtain a sub-licence to a Reserved Antigen (the "Collaborative Centre Sub-Licence Notice"). CAT shall grant such a sub-licence to the Collaborative Centre provided that the Collaborative Centre Sub-Licence Notice is given within [***] of the Collaborative Centre request or if later than [***] provided that the ...
Sample 1
RIGHTS GRANTED 2. 부여된 권리 2.1 Upon Oracle’s acceptance of Your order, You have the non-exclusive, non-assignable, royalty free, perpetual (unless otherwise specified in the order), limited right to use the Programs and receive any Program-related Service Offerings You ordered solely for Your internal business operations and subject to the terms of the Master Agreement, including the definitions and rules set forth in the order and the Program Documentation. 2.1. 오라클이 귀하의 주문을 승낙하는 때, 귀하는 프로그램을 사용할 수 있는 비독점적, 양도 불가능하며, 로열티가 없고, 영속적(달리 주문에 명시되지 않은 경우)이며, 제한된 권리를 가지며, 주문서 및 프로그램 설명서에 명시된 정의와 규칙을 비롯한 마스터 합의서 조항에 따라 귀하의 내부 업무 운영을 위해 귀하가 단독으로 주문한 프로그램 관련 서비스 제공물을 수령합니다. 2.2 Upon payment for Program-related Service Offerings, You have the non-exclusive, non- assignable, royalty free, perpetual, limited right to use for Your internal business operations anything developed by Oracle and delivered to You under this Schedule P (“deliverables”); however, certain deliverables may be subject to additional license terms provided in the order. 2.2. 프로그램 관련 서비스에 대한 요금을 지급하면 귀하는 오라클이 개발하고 본 명세서 P 에 의거 제공되는 모든 서비스(“산출물”)를 내부 업무 운영에 사용할 수 있는, 비독점적이고 양도 불가능하며 로열티가 없고 영속적이며 제한된 권리를 가집니다. 단, 특정 산출물에는 주문서에 명시된 추가 라이선스 조항이 적용될 수 있습니다. 2.3 You may allow Your agents and contractors (including, without limitation, outsourcers) to use the Programs and deliverables for Your internal business operations and You are responsible for their compliance with the General Terms and this Schedule P in such use. For Programs that are specifically designed to allow Your customers and suppliers to interact with You in the furtherance of Your internal business operations, such use is allowed under the General Terms and this Schedule P. 2.3. 귀하는 귀하의 대리인 및 하청업체(외주업체 등을 제한 없이 포함함)가 귀하의 내부 업무 운영을 위해 프로그램과 산출물을 사용하도록 허용할 수 있으며, 귀하의 대리인 등이 그러한 목적으로 산출물을 사용할 때 일반 조항과 본 명세서 P 를 준수하도록 할 책임은 귀하에게 있습니다. 귀하의 내부 업무 운영을 증진하기 위하여 귀하의 고객 및 공급업체가 귀하와 상호 교류할 수 있도록 특별히 설계된 프로그램의 경우, 이러한 사용은 일반 조항과 본 명세서 P 에 따라 허용됩니다. 2.4 You may make a sufficient number of copies of each Program for Your licensed use and one copy of each Program media. 2.4. 귀하는 라이선스 사용자를 위하여 각각의 프로그램에 대하여 충분한 매수의 사본과 각 프로그램 미디어의 사본 1 부를 제작할 수 있습니다.
Sample 1
RIGHTS GRANTED 2. 1 Subject to Customer’s compliance with this Customer Agreement and the Software Documentation, Samsung SDS hereby grants to Customer, and Customer hereby accepts, a non-exclusive, non-assignable, non- transferable, personal, royalty free, limited right, without right of sublicense, to use the Software for up to the number of licenses and for the license type (term) specified in the Ordering Document, solely for Customer’s own internal business operations.
Sample 1

Related to RIGHTS GRANTED 2

  • Rights Granted The Author hereby grants to the Publisher the perpetual, sole and exclusive, worldwide, transferable, sub-licensable and unlimited right to publish, produce, copy, distribute, communicate, display publicly, sell, rent and/or otherwise make available the Contribution in any language, in any versions or editions in any and all forms and/or media of expression (including without limitation in connection with any and all end-user devices), whether now known or developed in the future, in each case with the right to grant further time-limited or permanent rights. The above rights are granted in relation to the Contribution as a whole or any part and with or in relation to any other works. Without limitation, the above grant includes: (a) the right to edit, alter, adapt, adjust and prepare derivative works; (b) all advertising and marketing rights including without limitation in relation to social media; (c) rights for any training, educational and/or instructional purposes; and (d) the right to add and/or remove links or combinations with other media/works. The Author hereby grants to the Publisher the right to create, use and/or license and/or sub-license content data or metadata of any kind in relation to the Contribution or parts thereof (including abstracts and summaries) without restriction. The Publisher also has the right to commission completion of the Contribution in accordance with the Clause "Author’s Responsibilities – Delivery and Acceptance of the Manuscript" and of an updated version of the Contribution for new editions of the Work in accordance with the Clause "New Editions". The copyright in the Contribution shall be vested in the name of the Author. The Author has asserted their right(s) to be identified as the originator of the Contribution in all editions and versions, published in all forms and media. The Author agrees that all editing, alterations or amendments to the Contribution made by or on behalf of the Publisher or its licensees for the purpose of fulfilling this Agreement or as otherwise allowed by the above rights shall not require the approval of the Author and will not infringe the Author's "moral rights" (or any equivalent rights). This includes changes made in the course of dealing with retractions or other legal issues.

  • No Rights Granted Nothing in this Agreement shall be construed as granting any rights under any patent, copyright or other intellectual property right of the Company, nor shall this Agreement grant Advisor any rights in or to the Company’s Confidential Information, except the limited right to use the Confidential Information in connection with the Services.

  • Registration Rights Granted The Company hereby grants registration rights to the Purchaser pursuant to a Registration Rights Agreement dated as of even date herewith between the Company and the Purchaser.

  • No Other Rights Granted Proprietary Information shall remain the property of the Originating Party. Neither this Agreement nor disclosure of Proprietary Information hereunder shall be construed as granting any right or license under any trade secrets, copyrights, inventions, patents or other Intellectual Property now or hereafter owned or controlled by either Party.

  • Option Rights Except as provided below, the Option shall be valid for a term commencing on the Grant Date and ending 10 years after the Grant Date (the "EXPIRATION DATE").

  • License Granted Subject to the terms and conditions of this Agreement and in consideration of Licensee’s obligation to pay monetary fees as outlined in Schedule A, such fees which may be adjusted from time to time by mutual written consent of the parties, Licensor hereby grants, and Licensee hereby accepts, a worldwide, non-exclusive, non-transferable, irrevocable, perpetual right and licence, to use the Software and all related documentation for use in sports related mobile apps. Licensor also grants permission to Licensee to make and create customizations, updates or corrections to the Software. The parties agree that Licensor shall continue to own all right, title and interest in and to the Software and all intellectual property rights embodied therein or related thereto including, but not limited to, the source and object codes and any customizations, updates and corrections to the Software. Except as expressly provided herein, no intellectual property rights are granted to Licensee by implication, estoppel, or otherwise. Licensee will safeguard the Software and its related materials with that degree of normal due care commensurate with reasonable standards of industrial security for the protection of trade secrets and proprietary information so that no unauthorized use is made of them and no disclosure of any part of their contents is made to anyone other than Licensee’s employees, agents or consultants whose duties reasonably require such disclosure, or as necessary in the ordinary course of business. Licensee shall make all such persons fully aware of their responsibility to fulfill the obligations of Licensee under this Agreement.

  • License Rights The Recipient must provide a license to its “subject data” to the Federal Government, which license is: (a) Royalty-free, (b) Non-exclusive, and (c) Irrevocable, (2) Uses. The Federal Government’s license must permit the Federal Government to take the following actions provided those actions are taken for Federal Government purposes: (a) Reproduce the subject data, (b) Publish the subject data, (c) Otherwise use the subject data, and (d) Permit other entities or individuals to use the subject data, and

  • Issuance of Rights or Options If the Company in any manner issues or grants any warrants, rights or options, whether or not immediately exercisable, to subscribe for or to purchase Common Stock or other securities convertible into or exchangeable for Common Stock ("Convertible Securities") (such warrants, rights and options to purchase Common Stock or Convertible Securities are hereinafter referred to as "Options") and the price per share for which Common Stock is issuable upon the exercise of such Options is less than the Market Price on the date of issuance or grant of such Options, then the maximum total number of shares of Common Stock issuable upon the exercise of all such Options will, as of the date of the issuance or grant of such Options, be deemed to be outstanding and to have been issued and sold by the Company for such price per share. For purposes of the preceding sentence, the "price per share for which Common Stock is issuable upon the exercise of such Options" is determined by dividing (i) the total amount, if any, received or receivable by the Company as consideration for the issuance or granting of all such Options, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise of all such Options, plus, in the case of Convertible Securities issuable upon the exercise of such Options, the minimum aggregate amount of additional consideration payable upon the conversion or exchange thereof at the time such Convertible Securities first become convertible or exchangeable, by (ii) the maximum total number of shares of Common Stock issuable upon the exercise of all such Options (assuming full conversion of Convertible Securities, if applicable). No further adjustment to the Exercise Price will be made upon the actual issuance of such Common Stock upon the exercise of such Options or upon the conversion or exchange of Convertible Securities issuable upon exercise of such Options.

  • Anti-Dilution Rights (a) If at any time after the date hereof the Company declares or authorizes any dividend (other than a cash dividend), stock split, reverse stock split, combination, exchange of Shares, or there occurs any recapitalization, reclassification (including any consolidation or merger), sale or acquisition of property or stock, reorganization or liquidation, or if the outstanding Shares are changed into the same or a different number of Shares of the same or another class or classes of stock of the Company, then the Company shall cause effective provision to be made so that the Holder shall, upon exercise of this Warrant following such event, be entitled to receive the number of shares of stock or other securities or the cash or property of the Company (or of the successor corporation or other entity resulting from any consolidation or merger) to which the Warrant Shares (and any other securities) deliverable upon the exercise of this Warrant would have been entitled if this Warrant had been exercised immediately prior to the earlier of (i) such event and (ii) the record date, if any, set for determining the stockholders entitled to participate in such event, and the Exercise Price shall be adjusted appropriately so that the aggregate amount payable by the Holder upon the full exercise of this Warrant remains the same. The Company shall not effect any recapitalization, reclassification (including any consolidation or merger) unless, upon the consummation thereof, the successor corporation or entity shall assume by written instrument the obligation to deliver to the Holder the shares of stock, securities, cash or property that the Holder shall be entitled to acquire in accordance with the foregoing provisions, which instrument shall contain provisions calculated to ensure for the Holder, to the greatest extent practicable, the benefits provided for in this Warrant. (b) If, pursuant to the provisions of this paragraph 7, the Holder would be entitled to receive shares of stock or other securities upon the exercise of this Warrant in addition to the Shares issuable upon exercise of this Warrant, then the Company shall at all times reserve and keep available sufficient shares of other securities to permit the Company to issue such additional shares or other securities upon the exercise of this Warrant. (c) The Company shall at any time if so requested by the Holder furnish a written summary of all adjustments made pursuant to this paragraph 7 promptly following any such request.

  • Rights of Grantee The Restricted Shares subject to this grant shall be fully paid and nonassessable and shall be either: (i) represented by certificates held in custody by the Company until all restrictions thereon have lapsed, together with a stock power or powers executed by Grantee in whose name such certificates are registered, endorsed in blank and covering such Restricted Shares; or (ii) held at the Company’s transfer agent in book entry form with appropriate restrictions relating to the transfer of such Restricted Shares, and endorsed with an appropriate legend referring to the restrictions hereinafter set forth. Grantee shall have the right to vote the Restricted Shares. Upon vesting of the Restricted Shares hereunder, the Grantee: (x) shall receive cash dividends or cash distributions, if any, paid or made by the Company with respect to common shares after the Date of Grant and prior to the vesting of the Restricted Stock; and (y) shall receive any additional Restricted Shares that Grantee may become entitled to receive by virtue of a Restricted Share dividend, a merger or reorganization in which the Company is the surviving corporation or any other change in the capital structure of the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!